News About: Pharm. Industry
Dong-A targets W800 billion sales
Backed by active promotion of flagship products (e.g., Stillen, Zydena) and strenuous overseas expansion, Dong-A Pharm has set an ambitious goal of 800 billion won in sales and 100 billion in operating income this yea...
Daewoong teams up with Genexel-Sein to develop new biodrugs
Daewoong Pharm and Genexel-Sei, Inc. are to carry out a joint research for development of new antibodies, protein and biosimilar products.
The two companies exchanged a memorandum of understanding (MOU) in a signin...
Daewoong to file overseas patent application over new dementia treatment
Daewoong Pharm and Medifron DBT, a pharmaceutical company specializing in the development of neurological treatments, said on March 10 it will jointly file its patent application of DBT-1339, a novel treatment for Alz...
LG CNS to offer free medical check-ups
LG CNS said it would, in collaboration with the Korean Industrial Health Association, provide its free medical examination for a total of 100 employed working at two small- and mid-sized firms within this month, as pa...
Stem cells emerge as leading stock
Stem cell-related stocks have come back to the throne as the U.S. President Barack Obama will sign an executive order overturning President’s Bush’s embryonic stem cell research policy, according to Mirae Asset
Sto...
Samjin’s clopidogrel drug takes on Plavix
Samjin Pharm is enjoying brisk sales of its blood-thinning agent, Platless (clopidogrel).
Sales of Samjin’s Platless reached 25.5 billion since its release in January 2007, making it one of the top-selling drugs in...
Whanin to launch first generic of risedronate drug
Whanin Pharm says it will launch the first generic drug of Actonel (risedronate sodium) 35 mg as a weekly dosage.
The insurance price of risedronate 35 mg is valued at 6,435 won per tablet.
Risedronate is used t...
Glivec approved for GIST treatment
The Korea Food and Drug Administration on March 4 approved the Novartis drug Glivec (imatinib mesylate) for the treatment of patients with Kit (CD 117) positive unresectable (inoperable) and/or metastatic malignant ga...
Salespersons drain roils Korean drugmakers
The Korea Pharmaceutical Manufacturers Association said it has attentively watched the attempts of multinational companies stationed in Korea to scout experienced salespersons of Korean pharmaceutical firms.
“Forei...
KPMA chief to give warning to drugmakers
Korea Pharmaceutical Manufacturers Association (KPMA) Chairman Ur Choon-sun will issue a strong warning to drug manufacturers over their irregular business practices in a forthcoming meeting in order to induce volunta...
